Paper17697199
Meta-analysis: The utility and safety of heparin in the treatment of active ulcerative colitis.
Shen J and 3 others. Aliment Pharmacol Ther, 2007. Cited by 87 papers, by iCite.
Cite this record
ConductScience Library. Meta-analysis: The utility and safety of heparin in the treatment of active ulcerative colitis. Papers, record 17697199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17697199
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Meta-analysis: The utility and safety of heparin in the treatment of active ulcerative colitis.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anticoagulants | Major topic |
| Colitis, Ulcerative | Major topic |
| Heparin | Major topic |
| Analysis of Variance | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Male | |
| Odds Ratio | |
| Randomized Controlled Trials as Topic | |
| Sensitivity and Specificity | |
| Treatment Outcome |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40729235 | Cerebrovascular Thrombosis in Pediatric Ulcerative Colitis: A Case Report. | Reports (MDPI) | 2025 | https://conductscience.org/library/papers/40729235 | PubMed |
| 38407787 | Modern practical management of acute severe colitis. | Indian J Gastroenterol | 2024 | https://conductscience.org/library/papers/38407787 | PubMed |
| 38222957 | Standard and Extended Thromboprophylaxis in Patients with Inflammatory Bowel Disease: A Literature Review. | Euroasian J Hepatogastroenterol | 2023 | https://conductscience.org/library/papers/38222957 | PubMed |
| 38202258 | Venous Thromboembolism in Patients with Inflammatory Bowel Disease. | J Clin Med | 2023 | https://conductscience.org/library/papers/38202258 | PubMed |
| 37063454 | Inflammatory Bowel Disease Therapy and Venous Thromboembolism. | Curr Treat Options Gastroenterol | 2020 | https://conductscience.org/library/papers/37063454 | PubMed |
| 36278572 | Thromboembolic Events in Patients with Inflammatory Bowel Disease: A Comprehensive Overview. | Diseases | 2022 | https://conductscience.org/library/papers/36278572 | PubMed |
| 35608932 | Thromboprophylaxis Use in Paediatric Inflammatory Bowel Disease: An International RAND Appropriateness Panel. | J Crohns Colitis | 2022 | https://conductscience.org/library/papers/35608932 | PubMed |
| 34970430 | How to manage: acute severe colitis. | Frontline Gastroenterol | 2022 | https://conductscience.org/library/papers/34970430 | PubMed |
| 34734325 | Budding Multi-matrix Technology-a Retrospective Approach, Deep Insights, and Future Perspectives. | AAPS PharmSciTech | 2021 | https://conductscience.org/library/papers/34734325 | PubMed |
| 34599822 | The Incidence and Characteristics of Venous Thromboembolisms in Paediatric-Onset Inflammatory Bowel Disease: A Prospective International Cohort Study Based on the PIBD-SETQuality Safety Registry. | J Crohns Colitis | 2022 | https://conductscience.org/library/papers/34599822 | PubMed |
| 34453143 | International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease. | Nat Rev Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/34453143 | PubMed |
| 34377149 | Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management. | Ther Adv Gastroenterol | 2021 | https://conductscience.org/library/papers/34377149 | PubMed |
| 32256013 | Venous thromboembolism in inflammatory bowel disease. | World J Gastroenterol | 2020 | https://conductscience.org/library/papers/32256013 | PubMed |
| 31689354 | Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease. | Inflamm Bowel Dis | 2020 | https://conductscience.org/library/papers/31689354 | PubMed |
| 31562236 | British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. | Gut | 2019 | https://conductscience.org/library/papers/31562236 | PubMed |
| 25632199 | Colectomy is a risk factor for venous thromboembolism in ulcerative colitis. | World J Gastroenterol | 2015 | https://conductscience.org/library/papers/25632199 | PubMed |
| 25320522 | Inflammatory bowel disease and thromboembolism. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/25320522 | PubMed |
| 24839622 | Defining quality indicators for best-practice management of inflammatory bowel disease in Canada. | Can J Gastroenterol Hepatol | 2014 | https://conductscience.org/library/papers/24839622 | PubMed |
| 24744641 | Inflammatory bowel disease and thrombosis. | Turk J Haematol | 2012 | https://conductscience.org/library/papers/24744641 | PubMed |
| 24695669 | Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/24695669 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17697199
GET https://conductscience.org/api/papers/v1/17697199/cited_by?page=2